Fabless chipmaking small cap Sondrel (Holdings) PLC (AIM:SND)’s surprise rally on the AIM market showed no signs of slowing down on Monday.
Late last week, a Daily Mail feature quoting “a source with knowledge of the matter” revealed that Sondrel played a key part in developing Tesla boss Elon Musk’s brain–computer interface Neuralink.
According to sources, Musk called on Sondrel to lend its highly specialised knowledge of bespoke microchip designs to Neuralink, which was successfully implanted into a patient's brain for the first time last Sunday.
Though not confirmed by Sondrel, market sentiment went into overdrive, pushing shares over 160% higher last Thursday.
Evidently, there’s more gas left in the tank, with shares adding another 30% this Monday morning, bringing spot prices to 12.96p as of midday.